Semaglutide use may be increasing worldwide rates of ischemic optic neuropathy and retinal adverse events, a study suggests.

Corneal crosslinking (CXL) can be used to treat corneal neovascularization (CNV) if any causative infection is eradicated at the time of treatment or shortly thereafter, according to research ...

For patients undergoing noncardiac surgery, neurocognitive outcomes do not differ with hypotension-avoidance and hypertension-avoidance strategies.

A substantial number of US dementia cases could be eliminated by mitigating modifiable cardiometabolic risk factors.

High-dose HCQ use may lower the risk for diabetes among patients with pSS and can potentially mitigate the diabetogenic effects of glucocorticoids.

HealthDay News — A widespread decrease in measles-mumps-rubella (MMR) vaccination rates was seen after the COVID-19 pandemic, according to a research letter published online June 2 in the Journal of ...

A new injection to prevent HIV is expected to be approved by the US Food and Drug Administration (FDA) later this month.

The US Food and Drug Administration has approved a new lower-dose vaccine for active immunization against COVID-19 caused by severe acute respiratory syndrome coronavirus 2.

Patients who would benefit most from surgery and are least likely to benefit from continued medical therapy alone should be identified.

Following cataract surgery patients have a lower risk of dementia, although, this protective effect is diminished in those with CMD.

GLP-1 agonists may help reduce acetazolamide dosage in patients with idiopathic intracranial hypertension without changing clinical outcome.

Patients with diabetes who utilize GLP-1 RAs for 6 months or longer are twice as likely to develop neovascular age-related macular degeneration.